{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:48:47Z","timestamp":1790246927216,"version":"4.1.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/cad.0b013e328330e74e","type":"journal-article","created":{"date-parts":[[2009,12,4]],"date-time":"2009-12-04T03:19:07Z","timestamp":1259896747000},"page":"33-42","source":"Crossref","is-referenced-by-count":24,"title":["Characterization of the cytotoxic properties of the benzimidazole fungicides, benomyl and carbendazim, in human tumour cell lines and primary cultures of patient tumour cells"],"prefix":"10.1097","volume":"21","author":[{"given":"Daniel","family":"Laryea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Gullbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Isaksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nygren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210203","first-page":"553","article-title":"Study of carbendazim residue accumulation on greenhouse and field-grown strawberries, after successive treatments with benomyl","volume":"73","author":"Monico-Pifarre","year":"1990","journal-title":"J Assoc Off Anal Chem"},{"key":"R4-4-20210203","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0278-6915(90)90146-E","article-title":"Inhibitory action of benzimidazole fungicides on the in vivo incorporation of [3H]thymidine in various organs of the mouse","volume":"28","author":"Hellman","year":"1990","journal-title":"Food Chem Toxicol"},{"key":"R5-4-20210203","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/gyno.1994.1187","article-title":"Cytotoxic drug sensitivity testing of tumor cells from patients with ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA)","volume":"54","author":"Csoka","year":"1994","journal-title":"Gynecol Oncol"},{"key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ijc.2910460114","article-title":"Pharmacological modification of multi-drug resistance (MDR) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin A and verapamil on MDR leukemia T-cells","volume":"46","author":"Larsson","year":"1990","journal-title":"Int J Cancer"},{"key":"R7-4-20210203","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.bjc.6602699","article-title":"Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles","volume":"93","author":"Rickardson","year":"2005","journal-title":"Br J Cancer"},{"key":"R8-4-20210203","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/bjc.1996.453","article-title":"Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance","volume":"74","author":"Dhar","year":"1996","journal-title":"Br J Cancer"},{"key":"R9-4-20210203","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/toxsci\/59.1.138","article-title":"The role of GTP binding and microtubule-associated proteins in the inhibition of microtubule assembly by carbendazim","volume":"59","author":"Winder","year":"2001","journal-title":"Toxicol Sci"},{"key":"R10-4-20210203","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1365-2796.2003.01098.x","article-title":"Overview of the clinical efficacy of investigational anticancer drugs","volume":"253","author":"Nygren","year":"2003","journal-title":"J Intern Med"},{"key":"R11-4-20210203","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0041-008X(89)90211-1","article-title":"Serum and testicular testosterone and androgen binding protein profiles following subchronic treatment with carbendazim","volume":"101","author":"Rehnberg","year":"1989","journal-title":"Toxicol Appl Pharmacol"},{"key":"R12-4-20210203","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1073\/pnas.88.11.4825","article-title":"Selective activation of human heat shock gene transcription by nitrosourea antitumor drugs mediated by isocyanate-induced damage and activation of heat shock transcription factor","volume":"88","author":"Kroes","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R13-4-20210203","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4161\/cbt.2.3.364","article-title":"Mitoxantrone mediates demethylation and reexpression of cyclin d2, estrogen receptor and 14.3.3sigma in breast cancer cells","volume":"2","author":"Parker","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"R14-4-20210203","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.bmcl.2009.02.075","article-title":"Synthesis and evaluation of lysine derived sulfamides as histone deacetylase inhibitors","volume":"19","author":"Manku","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"R15-4-20210203","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ijc.22291","article-title":"STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines","volume":"120","author":"Fryknas","year":"2007","journal-title":"Int J Cancer"},{"key":"R16-4-20210203","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CAD.0b013e328330e74e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:11:00Z","timestamp":1786039860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-201001000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e328330e74e","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}